0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Muscle-on-a-Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-1U17212
Home | Market Reports | Health| Medical Devices & Equipment
Global Muscle on a Chip Market Research Report 2024
BUY CHAPTERS

Global Muscle-on-a-Chip Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-1U17212
Report
November 2025
Pages:166
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Muscle-on-a-Chip Market Size

The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Muscle-on-a-Chip Market

Muscle-on-a-Chip Market

Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
As an emerging market segment in the biomedical field, the muscle chip market has gradually attracted widespread attention from the industry in recent years. Muscle chips can simulate the structure and function of muscle tissue, providing a powerful tool for the research of muscle-related diseases, drug development and personalized medicine. Muscle chips have broad application potential in multiple fields, including diagnosis of muscle diseases, drug screening, toxicity testing, sports rehabilitation, and personalized medicine. By simulating the physiological and pathological processes of muscle tissue, muscle chips can help researchers gain a deeper understanding of the pathogenesis of muscle diseases, accelerate drug development, and improve treatment effects. Overall, the muscle chip market has broad development prospects and huge market potential.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Muscle-on-a-Chip market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Muscle-on-a-Chip Market Report

Report Metric Details
Report Name Muscle-on-a-Chip Market
Accounted market size in 2024 US$ 291 million
Forecasted market size in 2031 US$ 1445 million
CAGR 26.1%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Skeletal Muscle
  • Smooth Muscle
  • Other
Segment by Application
  • Pharmaceutical R&D
  • Sports Medicine
  • Sports Equipment Development
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Emulate, CN Bio, TissUse, Axion Biosystems, Nortis, BioIVT, InSphero, Mimetas, Ascendance Biotechnology, StemoniX, Tara Biosystems, BGI Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Muscle-on-a-Chip study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Muscle-on-a-Chip Market growing?

Ans: The Muscle-on-a-Chip Market witnessing a CAGR of 26.1% during the forecast period 2025-2031.

What is the Muscle-on-a-Chip Market size in 2031?

Ans: The Muscle-on-a-Chip Market size in 2031 will be US$ 1445 million.

Who are the main players in the Muscle-on-a-Chip Market report?

Ans: The main players in the Muscle-on-a-Chip Market are Emulate, CN Bio, TissUse, Axion Biosystems, Nortis, BioIVT, InSphero, Mimetas, Ascendance Biotechnology, StemoniX, Tara Biosystems, BGI Genomics

What are the Application segmentation covered in the Muscle-on-a-Chip Market report?

Ans: The Applications covered in the Muscle-on-a-Chip Market report are Pharmaceutical R&D, Sports Medicine, Sports Equipment Development

What are the Type segmentation covered in the Muscle-on-a-Chip Market report?

Ans: The Types covered in the Muscle-on-a-Chip Market report are Skeletal Muscle, Smooth Muscle, Other

1 Study Coverage
1.1 Introduction to Muscle-on-a-Chip: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Muscle-on-a-Chip Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Skeletal Muscle
1.2.3 Smooth Muscle
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Muscle-on-a-Chip Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical R&D
1.3.3 Sports Medicine
1.3.4 Sports Equipment Development
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Muscle-on-a-Chip Revenue Estimates and Forecasts 2020-2031
2.2 Global Muscle-on-a-Chip Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Muscle-on-a-Chip Sales Estimates and Forecasts 2020-2031
2.4 Global Muscle-on-a-Chip Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Muscle-on-a-Chip Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Muscle-on-a-Chip Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Skeletal Muscle Market Size by Manufacturers
3.5.2 Smooth Muscle Market Size by Manufacturers
3.5.3 Other Market Size by Manufacturers
3.6 Global Muscle-on-a-Chip Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Muscle-on-a-Chip Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Muscle-on-a-Chip Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Muscle-on-a-Chip Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Muscle-on-a-Chip Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Muscle-on-a-Chip Sales and Revenue by Type (2020-2031)
6.4 North America Muscle-on-a-Chip Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Muscle-on-a-Chip Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Muscle-on-a-Chip Sales and Revenue by Type (2020-2031)
7.4 Europe Muscle-on-a-Chip Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Muscle-on-a-Chip Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Muscle-on-a-Chip Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Muscle-on-a-Chip Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Muscle-on-a-Chip Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Muscle-on-a-Chip Sales and Revenue by Type (2020-2031)
9.4 Central and South America Muscle-on-a-Chip Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Muscle-on-a-Chip Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Muscle-on-a-Chip Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Muscle-on-a-Chip Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Muscle-on-a-Chip Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Emulate
11.1.1 Emulate Corporation Information
11.1.2 Emulate Business Overview
11.1.3 Emulate Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.1.4 Emulate Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Emulate Muscle-on-a-Chip Sales by Product in 2024
11.1.6 Emulate Muscle-on-a-Chip Sales by Application in 2024
11.1.7 Emulate Muscle-on-a-Chip Sales by Geographic Area in 2024
11.1.8 Emulate Muscle-on-a-Chip SWOT Analysis
11.1.9 Emulate Recent Developments
11.2 CN Bio
11.2.1 CN Bio Corporation Information
11.2.2 CN Bio Business Overview
11.2.3 CN Bio Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.2.4 CN Bio Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 CN Bio Muscle-on-a-Chip Sales by Product in 2024
11.2.6 CN Bio Muscle-on-a-Chip Sales by Application in 2024
11.2.7 CN Bio Muscle-on-a-Chip Sales by Geographic Area in 2024
11.2.8 CN Bio Muscle-on-a-Chip SWOT Analysis
11.2.9 CN Bio Recent Developments
11.3 TissUse
11.3.1 TissUse Corporation Information
11.3.2 TissUse Business Overview
11.3.3 TissUse Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.3.4 TissUse Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 TissUse Muscle-on-a-Chip Sales by Product in 2024
11.3.6 TissUse Muscle-on-a-Chip Sales by Application in 2024
11.3.7 TissUse Muscle-on-a-Chip Sales by Geographic Area in 2024
11.3.8 TissUse Muscle-on-a-Chip SWOT Analysis
11.3.9 TissUse Recent Developments
11.4 Axion Biosystems
11.4.1 Axion Biosystems Corporation Information
11.4.2 Axion Biosystems Business Overview
11.4.3 Axion Biosystems Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.4.4 Axion Biosystems Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Axion Biosystems Muscle-on-a-Chip Sales by Product in 2024
11.4.6 Axion Biosystems Muscle-on-a-Chip Sales by Application in 2024
11.4.7 Axion Biosystems Muscle-on-a-Chip Sales by Geographic Area in 2024
11.4.8 Axion Biosystems Muscle-on-a-Chip SWOT Analysis
11.4.9 Axion Biosystems Recent Developments
11.5 Nortis
11.5.1 Nortis Corporation Information
11.5.2 Nortis Business Overview
11.5.3 Nortis Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.5.4 Nortis Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Nortis Muscle-on-a-Chip Sales by Product in 2024
11.5.6 Nortis Muscle-on-a-Chip Sales by Application in 2024
11.5.7 Nortis Muscle-on-a-Chip Sales by Geographic Area in 2024
11.5.8 Nortis Muscle-on-a-Chip SWOT Analysis
11.5.9 Nortis Recent Developments
11.6 BioIVT
11.6.1 BioIVT Corporation Information
11.6.2 BioIVT Business Overview
11.6.3 BioIVT Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.6.4 BioIVT Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 BioIVT Recent Developments
11.7 InSphero
11.7.1 InSphero Corporation Information
11.7.2 InSphero Business Overview
11.7.3 InSphero Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.7.4 InSphero Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 InSphero Recent Developments
11.8 Mimetas
11.8.1 Mimetas Corporation Information
11.8.2 Mimetas Business Overview
11.8.3 Mimetas Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.8.4 Mimetas Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Mimetas Recent Developments
11.9 Ascendance Biotechnology
11.9.1 Ascendance Biotechnology Corporation Information
11.9.2 Ascendance Biotechnology Business Overview
11.9.3 Ascendance Biotechnology Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.9.4 Ascendance Biotechnology Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Ascendance Biotechnology Recent Developments
11.10 StemoniX
11.10.1 StemoniX Corporation Information
11.10.2 StemoniX Business Overview
11.10.3 StemoniX Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.10.4 StemoniX Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 StemoniX Recent Developments
11.11 Tara Biosystems
11.11.1 Tara Biosystems Corporation Information
11.11.2 Tara Biosystems Business Overview
11.11.3 Tara Biosystems Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.11.4 Tara Biosystems Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Tara Biosystems Recent Developments
11.12 BGI Genomics
11.12.1 BGI Genomics Corporation Information
11.12.2 BGI Genomics Business Overview
11.12.3 BGI Genomics Muscle-on-a-Chip Product Models, Descriptions and Specifications
11.12.4 BGI Genomics Muscle-on-a-Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 BGI Genomics Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Muscle-on-a-Chip Industry Chain
12.2 Muscle-on-a-Chip Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Muscle-on-a-Chip Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Muscle-on-a-Chip Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Muscle-on-a-Chip Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Muscle-on-a-Chip Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Muscle-on-a-Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Muscle-on-a-Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Muscle-on-a-Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Muscle-on-a-Chip Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Muscle-on-a-Chip Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Muscle-on-a-Chip Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Muscle-on-a-Chip Sales by Region (2020-2025) & (K Units)
 Table 8. Global Muscle-on-a-Chip Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Muscle-on-a-Chip Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Muscle-on-a-Chip Sales Share by Manufacturers (2020-2025)
 Table 12. Global Muscle-on-a-Chip Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Muscle-on-a-Chip Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Muscle-on-a-Chip by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle-on-a-Chip as of 2024)
 Table 16. Global Muscle-on-a-Chip Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Muscle-on-a-Chip Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Muscle-on-a-Chip Manufacturing Base and Headquarters
 Table 19. Global Muscle-on-a-Chip Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Muscle-on-a-Chip Sales by Type (2020-2025) & (K Units)
 Table 23. Global Muscle-on-a-Chip Sales by Type (2026-2031) & (K Units)
 Table 24. Global Muscle-on-a-Chip Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Muscle-on-a-Chip Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Muscle-on-a-Chip ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Muscle-on-a-Chip Sales by Application (2020-2025) & (K Units)
 Table 29. Global Muscle-on-a-Chip Sales by Application (2026-2031) & (K Units)
 Table 30. Muscle-on-a-Chip High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Muscle-on-a-Chip Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Muscle-on-a-Chip Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Muscle-on-a-Chip ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Muscle-on-a-Chip Growth Accelerators and Market Barriers
 Table 37. North America Muscle-on-a-Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Muscle-on-a-Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Muscle-on-a-Chip Growth Accelerators and Market Barriers
 Table 40. Europe Muscle-on-a-Chip Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Muscle-on-a-Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Muscle-on-a-Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Muscle-on-a-Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Muscle-on-a-Chip Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Muscle-on-a-Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Muscle-on-a-Chip Investment Opportunities and Key Challenges
 Table 47. Central and South America Muscle-on-a-Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Muscle-on-a-Chip Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Muscle-on-a-Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Emulate Corporation Information
 Table 51. Emulate Description and Major Businesses
 Table 52. Emulate Product Models, Descriptions and Specifications
 Table 53. Emulate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Emulate Sales Value Proportion by Product in 2024
 Table 55. Emulate Sales Value Proportion by Application in 2024
 Table 56. Emulate Sales Value Proportion by Geographic Area in 2024
 Table 57. Emulate Muscle-on-a-Chip SWOT Analysis
 Table 58. Emulate Recent Developments
 Table 59. CN Bio Corporation Information
 Table 60. CN Bio Description and Major Businesses
 Table 61. CN Bio Product Models, Descriptions and Specifications
 Table 62. CN Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. CN Bio Sales Value Proportion by Product in 2024
 Table 64. CN Bio Sales Value Proportion by Application in 2024
 Table 65. CN Bio Sales Value Proportion by Geographic Area in 2024
 Table 66. CN Bio Muscle-on-a-Chip SWOT Analysis
 Table 67. CN Bio Recent Developments
 Table 68. TissUse Corporation Information
 Table 69. TissUse Description and Major Businesses
 Table 70. TissUse Product Models, Descriptions and Specifications
 Table 71. TissUse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. TissUse Sales Value Proportion by Product in 2024
 Table 73. TissUse Sales Value Proportion by Application in 2024
 Table 74. TissUse Sales Value Proportion by Geographic Area in 2024
 Table 75. TissUse Muscle-on-a-Chip SWOT Analysis
 Table 76. TissUse Recent Developments
 Table 77. Axion Biosystems Corporation Information
 Table 78. Axion Biosystems Description and Major Businesses
 Table 79. Axion Biosystems Product Models, Descriptions and Specifications
 Table 80. Axion Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Axion Biosystems Sales Value Proportion by Product in 2024
 Table 82. Axion Biosystems Sales Value Proportion by Application in 2024
 Table 83. Axion Biosystems Sales Value Proportion by Geographic Area in 2024
 Table 84. Axion Biosystems Muscle-on-a-Chip SWOT Analysis
 Table 85. Axion Biosystems Recent Developments
 Table 86. Nortis Corporation Information
 Table 87. Nortis Description and Major Businesses
 Table 88. Nortis Product Models, Descriptions and Specifications
 Table 89. Nortis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Nortis Sales Value Proportion by Product in 2024
 Table 91. Nortis Sales Value Proportion by Application in 2024
 Table 92. Nortis Sales Value Proportion by Geographic Area in 2024
 Table 93. Nortis Muscle-on-a-Chip SWOT Analysis
 Table 94. Nortis Recent Developments
 Table 95. BioIVT Corporation Information
 Table 96. BioIVT Description and Major Businesses
 Table 97. BioIVT Product Models, Descriptions and Specifications
 Table 98. BioIVT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. BioIVT Recent Developments
 Table 100. InSphero Corporation Information
 Table 101. InSphero Description and Major Businesses
 Table 102. InSphero Product Models, Descriptions and Specifications
 Table 103. InSphero Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. InSphero Recent Developments
 Table 105. Mimetas Corporation Information
 Table 106. Mimetas Description and Major Businesses
 Table 107. Mimetas Product Models, Descriptions and Specifications
 Table 108. Mimetas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Mimetas Recent Developments
 Table 110. Ascendance Biotechnology Corporation Information
 Table 111. Ascendance Biotechnology Description and Major Businesses
 Table 112. Ascendance Biotechnology Product Models, Descriptions and Specifications
 Table 113. Ascendance Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Ascendance Biotechnology Recent Developments
 Table 115. StemoniX Corporation Information
 Table 116. StemoniX Description and Major Businesses
 Table 117. StemoniX Product Models, Descriptions and Specifications
 Table 118. StemoniX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. StemoniX Recent Developments
 Table 120. Tara Biosystems Corporation Information
 Table 121. Tara Biosystems Description and Major Businesses
 Table 122. Tara Biosystems Product Models, Descriptions and Specifications
 Table 123. Tara Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Tara Biosystems Recent Developments
 Table 125. BGI Genomics Corporation Information
 Table 126. BGI Genomics Description and Major Businesses
 Table 127. BGI Genomics Product Models, Descriptions and Specifications
 Table 128. BGI Genomics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. BGI Genomics Recent Developments
 Table 130. Key Raw Materials Distribution
 Table 131. Raw Materials Key Suppliers
 Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 133. Milestones in Production Technology Evolution
 Table 134. Distributors List
 Table 135. Market Trends and Market Evolution
 Table 136. Market Drivers and Opportunities
 Table 137. Market Challenges, Risks, and Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Muscle-on-a-Chip Product Picture
 Figure 2. Global Muscle-on-a-Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Skeletal Muscle Product Picture
 Figure 4. Smooth Muscle Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Muscle-on-a-Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Pharmaceutical R&D
 Figure 8. Sports Medicine
 Figure 9. Sports Equipment Development
 Figure 10. Muscle-on-a-Chip Report Years Considered
 Figure 11. Global Muscle-on-a-Chip Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Muscle-on-a-Chip Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Muscle-on-a-Chip Revenue Market Share by Region (2020-2031)
 Figure 15. Global Muscle-on-a-Chip Sales (2020-2031) & (K Units)
 Figure 16. Global Muscle-on-a-Chip Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Muscle-on-a-Chip Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Muscle-on-a-Chip Sales Volume Market Share in 2024
 Figure 19. Global Muscle-on-a-Chip Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Skeletal Muscle Revenue Market Share by Manufacturer in 2024
 Figure 22. Smooth Muscle Revenue Market Share by Manufacturer in 2024
 Figure 23. Other Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Muscle-on-a-Chip Sales Market Share by Type (2020-2031)
 Figure 25. Global Muscle-on-a-Chip Revenue Market Share by Type (2020-2031)
 Figure 26. Global Muscle-on-a-Chip Sales Market Share by Application (2020-2031)
 Figure 27. Global Muscle-on-a-Chip Revenue Market Share by Application (2020-2031)
 Figure 28. North America Muscle-on-a-Chip Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Muscle-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Muscle-on-a-Chip Sales Revenue (US$ Million) in 2024
 Figure 31. North America Muscle-on-a-Chip Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Muscle-on-a-Chip Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Muscle-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Muscle-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Muscle-on-a-Chip Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Muscle-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Muscle-on-a-Chip Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Muscle-on-a-Chip Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Muscle-on-a-Chip Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Muscle-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Muscle-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 46. France Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Muscle-on-a-Chip Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Muscle-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Muscle-on-a-Chip Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Muscle-on-a-Chip Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Muscle-on-a-Chip Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Muscle-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Muscle-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 61. India Muscle-on-a-Chip Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Muscle-on-a-Chip Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Muscle-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Muscle-on-a-Chip Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Muscle-on-a-Chip Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Muscle-on-a-Chip Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Muscle-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Muscle-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Muscle-on-a-Chip Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Muscle-on-a-Chip Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Muscle-on-a-Chip Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Muscle-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Muscle-on-a-Chip Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Muscle-on-a-Chip Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Muscle-on-a-Chip Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Muscle-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Muscle-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Muscle-on-a-Chip Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Muscle-on-a-Chip Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Muscle-on-a-Chip Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Muscle-on-a-Chip Revenue (2020-2025) & (US$ Million)
 Figure 82. Muscle-on-a-Chip Industry Chain Mapping
 Figure 83. Regional Muscle-on-a-Chip Manufacturing Base Distribution (%)
 Figure 84. Global Muscle-on-a-Chip Production Market Share by Region (2020-2031)
 Figure 85. Muscle-on-a-Chip Production Process
 Figure 86. Regional Muscle-on-a-Chip Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart